$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
克唑替尼治疗ROS1重排非小细胞肺癌:从反应到耐药
2025-10-19 11:44:20
Check Details
克唑替尼在ALK+肺癌患者中的治疗模式和生存期:加拿大回顾性研究
2025-10-19 11:44:20
Check Details
阿法替尼作为HER2突变肺腺癌患者的一线治疗:病例报告
2025-10-19 11:44:20
Check Details
艾乐替尼可能使肺癌恢复对克唑替尼的敏感性:病例报告
2025-10-19 11:44:20
Check Details
阿法替尼和奥希替尼序贯治疗EGFR突变阳性非小细胞肺癌:真实世界研究
2025-10-19 11:44:20
Check Details
三线克唑替尼治疗有脑转移和体力状态较差非小细胞肺癌患者
2025-10-19 11:44:20
Check Details
克唑替尼vs培美曲塞化疗在中国ROS1重排肺癌患者中的疗效
2025-10-19 11:44:20
Check Details
曲美替尼+莫莫替尼治疗转移性KRAS突变肺癌1B期研究
2025-10-19 11:44:20
Check Details
三种一线EGFR酪氨酸激酶抑制剂预防和治疗肺癌脑转移
2025-10-19 11:44:20
Check Details
克唑替尼治疗缓解罕见ALK融合非小细胞肺癌
2025-10-19 11:44:20
Check Details
皮质类固醇激素治疗阿法替尼诱导的间质性肺病:病例报告
2025-10-19 11:44:20
Check Details
克唑替尼治疗非小细胞肺癌后肾脏并发症的影像学特征:病例报告
2025-10-19 11:44:20
Check Details
1
2
...
9090
9091
9092
9093
9094
9095
9096
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
2
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
3
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
4
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
5
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
6
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
7
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
8
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
9
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
10
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
11
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
12
Complete Guide to Dosage and Dose Adjustment of Entrectinib